Basic Information

Gene symbol tk

GTO ID GTC1097
Trial ID IRCT20200502047277N2
Disease Glioblastoma
Altered gene tk
Therapeutic/Target gene Therapeutic gene
TherapyGene transfer
Treatment HSV-TK LV cells
PhasePhase1
Recruitment statusCompleted
TitleIntracerebral Administration of Allogeneic/Autologous Mesenchymal Stem Cells as HSV-TK Gene Vehicle for Treatment of Glioblastoma: Safety and Feasibility Assessment
Year2020
CountryIran (Islamic )
Company sponsorShahid Beheshti University of Medical Sciences
Vector information
Vectorlentivirus
Transgene/Inserted geneThymidine Kinase gene

Clinical Result

Cohort 1
Administration route intratumoral injection
Dosage 5E5 cells
Donor type Autologous|Allogeneic
Pts 5
Age No limit

Relationship Graph

Overview of Knowledge Graph